News for Healthier Living

Large Disparities in Adoption of Alzheimer's Infusion Therapy Raise Concerns About Access

Adoption of lecanemab, a novel infusion treatment for Alzheimer's disease (AD), has been disproportionately higher among patients who are male, white, from urban areas, and have higher socioeconomic status, highlighting how certain populations are more likely to access potentially breakthrough new therapies than others

May 15, 2025


May 16 2025

May 15 2025

May 14 2025

May 13 2025

May 12 2025

May 11 2025

May 10 2025

May 9 2025

May 8 2025

May 7 2025

May 6 2025

May 5 2025